Description of Medical Areas

About the FDA Approved Listings

Approved Drugs for Otolaryngology

Drugs Approved in 2008

  • Moxatag (amoxicillin); For the treatment of tonsillitis and/or pharyngitis secondary to Streptococcus pyogenes in adults and pediatrics; MiddleBrooke Pharmaceuticals; Approved January 2008
  • Patanase (olopatadine hydrochloride); For the treatment of seasonal allergic rhinitis; Alcon; Approved April 2008

Drugs Approved in 2007

Drugs Approved in 2006

No approvals recorded for Otolaryngology in 2006.

Drugs Approved in 2005

No approvals recorded for Otolaryngology in 2005.

Drugs Approved in 2004

No approvals recorded for Otolaryngology in 2004.

Drugs Approved in 2003

No approvals recorded for Otolaryngology in 2003.

Drugs Approved in 2002

No approvals recorded for Otolaryngology in 2002.

Drugs Approved in 2001

No approvals recorded for Otolaryngology in 2001.

Drugs Approved in 2000

Drugs Approved in 1999

  • Ethyol (amifostine); Treatment for xerostomia (dry mouth) due to radiation; U.S. Bioscience, Alza; Approved June 1999

Drugs Approved in 1998

  • Rocephin; Treatment for pediatric otitis media; Roche; Approved January 1998
  • Rocephin; Treatment for acute otitis media; Roche; Approved January 1998

Drugs Approved in 1997

  • Floxin otic; Treatment for otitis media; Daiichi Pharmaceutical; Approved December 1997
  • Omnicef; Treatment against various bacterias; Warner-Lambert; Approved December 1997

Drugs Approved in 1996

Drugs Approved in 1995

  • Cedax (ceftibuten); Treatment for chronic bronchitis, acute bacterial otitis media, pharyngitis/tonsillitis; Schering-Plough; Approved December 1995


Back to Centerwatch Drug Approvals

Drug listings last updated: May 16, 2008 at 3:40:47 PM

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA